J.P. Morgan Logo
30 Apr 2014
Emerging Europe Emerging Markets Research

Turkey: external rebalancing is gaining momentum

 
 
- The foreign trade data produced the second market friendly surprise in a row.
- The recovery in gold exports contributed significantly, but even excluding gold, exports continue growing at a respectable pace
- External rebalancing will likely gain pace in the coming months.
March foreign trade data confirmed that Turkey’s external rebalancing has started gaining momentum. In fact, the foreign trade data surprised in a market friendly way for the second consecutive month in a row. We expect this process to gain pace in the coming months and see the current account deficit narrowing from US$65 billion (7.9% of GDP) in 2013 to US$46 billion (5.7% of GDP) in 2014.
Turkey posted a foreign trade deficit of US$5.2 billion, down 30.1%oya in March. The result compared favorably with the market consensus and the J.P.Morgan forecasts which stood at US$5.7 billion and US$5.5 billion, respectively. Exports reached US$14.7 billion, up 12.4%oya and imports were US$19.9 billion, down 3.0%oya in March. True, part of the improvement was thanks to the rise in gold exports, but exports were up 4.8%oya even when gold exports were excluded.
GPSWebNote Image
Going forward, we expect the improvement in external balances to continue mainly because 1) higher interest rates, macroprudential measures and tax hikes implemented by the government and poor sentiment all lead to weaker domestic demand and hence lower imports; 2) the currency depreciation enhances the competitive power of Turkish exporters; 3) Turkey continues benefitting from the recovery in EU demand; and 4) the improvement in gold trade will likely continue. Actually some of these factors were already present in the March foreign trade data. For instance, Turkey’s exports to the EU countries increased 13.5%oya in the third months of the year. Especially worth noting were the exports to Germany (up 16%), the UK (up 30%) and Poland (up 21%). Continued penetration into the Iraq market (exports to Iraq were up 8% in March) and the improvement in the relations with Israel (exports to Israel were up 25%oya) were some of the other factors behind the export strength. Not surprisingly March saw a 15%oya decline in exports to Russia.
As far as imports are concerned, March data confirmed the weakness in consumption demand while showed recovery in investment appetite. While capital good imports were up 8.3%y/y, consumer good imports were down 12.0%y/y in March. In fact, this is in line with the developments in the loan market. There has been a sharp slowdown in consumer loan growth while commercial loan growth remains robust. That suggests that this favorable trend will continue, supporting the macro financial stability, the rebalancing process and the decrease in inflation.
Finally, a monthly trade deficit of US$5.2 billion will likely translate into a current account deficit of US$3.4 billion in March. As a result, the 12-month trailing CAD will likely fall sharply to US$59.9 billion in March from US$62.2 billion in February.


(90-212) 319-8599
JPMorgan Chase Bank N.A, Istanbul Branch
  


 

www.jpmorganmarkets.com


The research analyst(s) denoted by an "AC" in this report individually certifies, with respect to each security or issuer that the research analyst covers in this research, that: (1) all of the views expressed in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s) in this report.

Company-Specific Disclosures: Important disclosures, including price charts, are available for compendium reports and all J.P. Morgan–covered companies by visiting https://jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request. J.P. Morgan’s Strategy, Technical, and Quantitative Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail research.disclosure.inquiries@jpmorgan.com.

Confidentiality and Security Notice: This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format.